Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer

Withdrawn before enrolling

Conditions studied: Hematopoietic/Lymphoid Cancer, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific

In brief

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at molecular markers and genetic markers in patients undergoing radiation therapy for cancer.

Key facts

Study ID

NCT00899808

Run by

Rutgers, The State University of New Jersey

People needed

0

Starts

2006-05-01

Last updated by the study team

2015-05-29

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Rutgers Cancer Institute of New Jersey - Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.